This decreased expression was observed in several genes throughout the signaling pathway, and specifically included reduced expression of MAP3K14, NFKB2, TRAF3, STAT3, CXCL12, CXCL13, CXCR4, and CCR7 that were not observed in the other IBD patient groups. This evidence concerns the gene CXCR4 and inflammatory bowel disease.